Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Other Non-Current Liabilities (2021 - 2025)

Roivant Sciences' Other Non-Current Liabilities history spans 5 years, with the latest figure at $677000.0 for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities rose 120.52% year-over-year to $677000.0; the TTM value through Dec 2025 reached $677000.0, up 120.52%, while the annual FY2025 figure was $22000.0, 99.12% down from the prior year.
  • Other Non-Current Liabilities reached $677000.0 in Q4 2025 per ROIV's latest filing, up from $170000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $21.9 million in Q1 2022 to a low of $22000.0 in Q1 2025.
  • Average Other Non-Current Liabilities over 5 years is $7.1 million, with a median of $6.7 million recorded in 2022.
  • Peak YoY movement for Other Non-Current Liabilities: soared 168.37% in 2022, then tumbled 99.12% in 2025.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $8.2 million in 2021, then surged by 162.68% to $21.5 million in 2022, then tumbled by 79.38% to $4.4 million in 2023, then tumbled by 93.07% to $307000.0 in 2024, then skyrocketed by 120.52% to $677000.0 in 2025.
  • Per Business Quant, the three most recent readings for ROIV's Other Non-Current Liabilities are $677000.0 (Q4 2025), $170000.0 (Q3 2025), and $228000.0 (Q2 2025).